MGMert Gur

Mert Gur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mert Gur has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Attraction to Repulsion: Omicron-Driven Rewiring of Nanobody Interfaces on the SARS-CoV-2 RBD

    by Mert Golcuk, Fareeda E. Abu-Juam, Derman Basturk, Ayten Dilara Gursel, Clara Xazal Buran, Reyhan Metin Akkaya, Ahmet Yildiz, Mert Gur

    Mutations in the SARS-CoV-2 Omicron spike receptor-binding domain (RBD) enable broad escape from neutralizing nanobodies (Nbs), yet the molecular basis of epitope-dependent binding loss remains unclear. We performed all-atom molecular dynamics (MD) simulations of 13 Nbs bound to Omicron RBD to characterize binding stability, interfacial dynamics, and unbinding mechanisms. Most Nbs occupied a dominant conformational basin but exhibited varying heterogeneity and orientation shifts, whereas Nb21 and Sb14 showed pronounced pose plasticity and dissociation. Covariance matrix analysis of the remaining 11 complexes identified stabilizing hydrophobic anchor patches within the receptor-binding motif and Nb-specific interaction networks. Omicron substitutions rewired these networks, altered Nb orientations relative to the corresponding experimentally determined wild-type RBD-bound reference structures (Alpha/Kent for H3), and introduced unfavorable repulsive interactions directly at mutation sites or indirectly through reorientation. Low-speed steered MD simulations were performed at a pulling velocity within the range used in high-speed atomic force microscopy-based force spectroscopy. These simulations yielded lower mean unbinding work for all 11 Nbs than for ACE2. Nb dissociation proceeded through heterogeneous, stepwise pathways in which receptor-binding ridge interactions maintained partial attachment and stabilized transient intermediates. Together, these simulations reveal epitope-specific interaction fingerprints, mutation-induced destabilization mechanisms, and pathway-resolved determinants underlying diminished Nb binding to Omicron RBD.

  • Characterizing dynamics of productive dynein stepping by MINFLUX

    by Joseph Slivka, Emma S. Gleave-Hanford, Mert Golcuk, Devinda P. Wijewardena, John T. Canty, Paul R. Selvin, Mert Gur, Andrew P. Carter, Ahmet Yildiz


  • Mapping the peptide interaction fingerprint of the Behçet’s disease-associated HLA-B∗51

    by Sema Zeynep Yilmaz, Derman Basturk, Ahmet Gul, Burak Erman, Mert Gur

  • Open Access

    Small Molecule Activators of Protein Phosphatase 2A Exert Global Stabilizing Effects on the Scaffold PR65

    by Mohsin M. Naqvi, Maria Zacharopoulou, Satyaki Saha, Anupam Banerjee, Sema Z. Yilmaz, Vanda Sunderlikova, Chris M. Johnson, Janet R. Kumita, Shang-Hua Yang, Reuven Gordon, et al.

    Protein phosphatase 2A (PP2A), an important therapeutic target, comprises scaffold subunit PR65 composed of 15 HEAT (Huntingtin/Elongation/A-subunit/TOR1) repeats, a catalytic subunit, and one of many different regulatory subunits that enable binding to specific substrates. Recently, small molecule activators of PP2A (SMAPs) were identified, although their mechanisms of action have not yet been fully defined. Here, we explore the interaction of PR65 with two SMAPs, ATUX-8385 and the nonfunctional DBK-776, using single-molecule optical tweezers, ensemble methods, and computational analysis. In the absence of SMAP, PR65 shows multiple unfolding and refolding transitions, and the force–extension profiles are very heterogeneous with evidence of misfolding. Similar heterogeneity has been observed for the chemical-induced unfolding of tandem-repeat proteins like PR65, a consequence of the internal symmetry of the repeat architecture. In the presence of ATUX-8385, higher unfolding and refolding forces are observed throughout the structure and there is less misfolding, suggesting that ATUX-8385 acts like a pharmacological chaperone. In contrast, DBK-766-binding induces higher unfolding forces only for a few repeats of PR65, suggestive of a more localized effect; moreover, subsequent stretch–relax cycles show that PR65 is irreversibly locked in the unfolded state. Docking and molecular dynamics simulations provide insights into the distinctive responses of PR65 to mechanical stress in the presence of these two SMAPs: ATUX-8385 stably binds to a key site in the inner face of the PR65 structure, stabilizing a conformation predisposed to associate with the catalytic and regulatory subunits of PP2A. DBK-766, in contrast, exhibits a weaker binding to the outer face of PR65 and elicits relatively large conformational fluctuations in PR65 when bound to the compact form.


  • Open Access

    Small Molecule Activator of Phosphatase PP2A Remodels Scaffold PR65 Structural Dynamics To Promote Holoenzyme Assembly

    by Sema Z. Yilmaz, Anupam Banerjee, Satyaki Saha, Michael Ohlmeyer, Reuven Gordon, Laura S. Itzhaki, Ivet Bahar, Mert Gur

    Small molecule activators of protein phosphatase 2A (PP2A), hereafter SMAPs, have attracted substantial interest for their potential to inhibit cancer cell proliferation by targeting PR65, the scaffold subunit of the PP2A heterotrimer. PR65 is a uniquely flexible and stable molecule composed of 15 tandem HEAT (Huntingtin, Elongation factor 3–PP2A–TOR1) repeats. We characterized the binding sites and interactions of two SMAPs ATUX-8385 and DT-061 with PR65 and evaluated the effects on PR65 structural dynamics using docking and molecular dynamics simulations. We initiated SMAP-bound PR65 simulations starting from two binding sites: S1, determined by cryo-electron microscopy for DT-061 bound to PP2A, on the inner helices of the HEAT repeats 2 and 3 (2i and 3i); and S2, predicted by docking of ATUX-8385 onto PR65, on 4i and 5i and outer helices 5o and 6o consistent with footprinting experiments. S2 proved to be a stable site for both SMAPs when simulations were initiated at S2. However, neither DT-061 nor ATUX-8385 demonstrated stable binding to S1. DT-061 rapidly dissociated from S1 to settle instead at a neighboring site S4 overlapping with our previously identified S3 for PR65 in extended form, suggesting that binding to S1 may be a two-step process: an initial binding to PR65 alone, either to S3/S4 or S2, followed by movement to S3/S4, and then an induced relocation to S1 upon complexation with the regulatory and catalytic subunits. Targeted in silico mutagenesis showed that mutations at S2 and S4 destabilized binding of SMAP to PR65 (subunit). Heterotrimeric PP2A simulations showed that S3 and S4 bindings were not persistent upon complexation. Together, these results corroborate our findings. Furthermore, this preferentially stabilized a relatively extended PR65 conformation that would accommodate, if not promote, the assembly of the catalytic and regulatory subunits to prompt the activation of the trimeric phosphatase.


  • Open Access

    Mapping the Peptide Interaction Fingerprint of the Behçet’s disease associated HLA-B*51

    by Sema Zeynep Yilmaz, Derman Basturk, Ahmet Gul, Burak Erman, Mert Gur

    The strongest genetic risk factor for Behçet’s disease, a relapsing inflammatory disorder marked by recurrent mucocutaneous ulcers and uveitis, is an allele of the class I major histocompatibility complex (MHC-I) molecule, which presents intracellular peptides to CD8 + T cells. The molecular mechanisms linking the peptide preferences of this allele (HLA-B*51:01) to dysregulated immunity remain unclear, limiting efforts to design peptide-based modulators of antigen presentation. Here, we define HLA-B*51:01’s peptide selection rules by mapping the “interaction fingerprint” of 36 self-peptides using long-duration all-atom MD simulations. These uncovered a conserved hydrophobic–polar blueprint that is tuned by peptide length. High-speed atomic force microscopy rate in silico pulling experiments suggest a three-tier hierarchy of mechanical resilience: 9-mers resist the highest forces, 8-mers exhibit intermediate resistance, and 10/11-mers rupture most easily. Our comprehensive analysis provides an atomistic framework for understanding the molecular mechanisms underlying HLA-B*51:01 pathobiology and offers quantitative parameters to guide the design of therapeutic peptides or small molecules to modulate antigen presentation in Behçet’s disease. STATEMENT OF SIGNIFICANCE: Behçet’s disease is strongly linked to HLA-B*51:01, a molecule that displays protein fragments to killer T cells, yet how this allele selects its peptides is poorly understood. Here, we combine all-atom equilibrium molecular dynamics simulations with steered MD pulling simulations that mimic high-speed atomic force microscopy experiments to map how 36 self-peptides of different lengths engage the HLA-B*51:01 groove. We uncover a conserved hydrophobic–polar interaction blueprint and show that 9-mers form the mechanically most resilient complexes, whereas shorter or longer peptides detach more easily under force. This length-tuned interaction “fingerprint” provides an atomistic framework for understanding HLA-B*51:01-driven immune dysregulation and guides the rational design of peptide-based or small-molecule modulators for Behçet’s disease.

  • Open Access

    Small molecule activator of phosphatase PP2A remodels scaffold PR65 structural dynamics to promote holoenzyme assembly

    by Sema Z. Yilmaz, Anupam Banerjee, Satyaki Saha, Michael Ohlmeyer, Reuven Gordon, Laura S. Itzhaki, Ivet Bahar, Mert Gur

    Small molecule activators of protein phosphatase 2A (PP2A), hereafter SMAPs, have attracted substantial interest, for their potential to inhibit cancer cell proliferation by targeting PR65, the scaffold subunit of the PP2A heterotrimer. PR65 is a uniquely flexible and stable molecule composed of 15 tandem HEAT (Huntingtin, Elongation factor 3–PP2A–TOR1) repeats. We characterized the binding sites and interactions of two SMAPs ATUX-8385 and DT-061 with PR65 and evaluated effects on PR65 structural dynamics using docking and molecular dynamics simulations. We initiated SMAP-bound PR65 simulations starting from two binding sites: S1, determined by cryo-electron microscopy for DT-061 bound to PP2A, on the inner helices of the HEAT repeats 2 and 3 (2 i and 3 i ); and S2, predicted by docking of ATUX-8385 onto PR65, on 4 i and 5 i and outer helices 5 o and 6 o consistent with footprinting experiments. S2 proved to be a stable site for both SMAPs when initiating the simulations at S2. However, neither DT-061 nor ATUX-8385 demonstrated stable binding to S1. DT-061 rapidly dissociated from S1 to settle instead at a neighboring site S4 overlapping with our previously identified S3 for PR65 in extended form, suggesting that binding to S1 may be a 2-step process: an initial binding to PR65 alone, either to S3/S4 or S2, followed by movement to S3/S4, and then an induced relocation to S1 upon complexation with the regulatory and catalytic subunits. Targeted in silico mutagenesis showed that mutations at S2 and S4 destabilized SMAP binding to the PR65 (subunit). Heterotrimeric PP2A simulations showed that S3 and S4 binding were not persistent upon complexation. Together, these results corroborate our findings. Furthermore, preferentially stabilized a relatively extended PR65 conformation that would accommodate, if not promote, the assembly of the catalytic and regulatory subunits to prompt the activation of the trimeric phosphatase.

  • Open Access

    A Practical Covariance-Based Method for Efficient Detection of Protein–Protein Attractive and Repulsive Interactions in Molecular Dynamics Simulations

    by Mert Golcuk, Mert Gur

    Molecular dynamics simulations of large protein-protein complexes require scalable analysis. We present a correlation-based workflow that systematically identifies both attractive (stabilizing) interactions, such as salt bridges, and repulsive (destabilizing) interactions, such as same-charge electrostatic repulsions, across extensive interfaces. By constructing an interprotein covariance matrix, filtering residue pairs by distance, and identifying interactions underlying these correlations, our method focuses computational resources on the most relevant regions of the interface while preserving a high level of detail.


  • Open Access

    Structural basis of Pseudomonas biofilm-forming functional amyloid FapC formation

    by Kasper Holst Hansen, Mert Golcuk, Chang Hyeock Byeon, Abdulkadir Tunc, Emilie Buhl Plechinger, Morten K. D. Dueholm, James F. Conway, Maria Andreasen, Mert Gur, Ümit Akbey

    Biofilm-protected Pseudomonas aeruginosa causes chronic infections that are difficult to treat. FapC, the major biofilm-forming functional amyloid in Pseudomonas , is essential for biofilm integrity, yet its structural details remain unresolved. Using an integrative structural biology approach, we combine a solution nuclear magnetic resonance–based structural ensemble of unfolded monomeric FapC, a ~3.3-angstrom-resolution cryo–electron microscopy (cryo-EM) density map of FapC fibril, and all-atom molecular dynamics (MD) simulations to capture the transition from the unfolded to folded monomer to the fibrillar fold, providing a complete structural view of FapC biogenesis. Cryo-EM reveals a unique irregular triple-layer β solenoid cross-β fibril composed of a single protofilament. MD simulations initiated from monomeric and fibrillar FapC mapped structural transitions, offering mechanistic insights into amyloid assembly and disassembly. Understanding FapC reveals how Pseudomonas exploits functional amyloids for biofilm formation, and establishes a structural and mechanistic foundation for developing therapeutics targeting biofilm-related infection and antimicrobial resistance.


  • Open Access

    Small Molecule Activators of Protein Phosphatase 2A Exert Global Stabilising Effects on the Scaffold PR65

    by Mohsin M Naqvi, Maria Zacharopoulou, Satyaki Saha, Anupam Banerjee, Zeynep S Yilmaz, Vanda Sunderlikova, Chris M Johnson, Janet R Kumita, Shang-Hua Yang, Reuven Gordon, et al.

    Protein phosphatase 2A (PP2A), an important therapeutic target, comprises a scaffold subunit PR65 composed of 15 HEAT (Huntingtin/elongation/A-subunit/TOR1) repeats, a catalytic subunit, and one of many different regulatory subunits that enable binding to specific substrates. Recently, small molecule activators of PP2A (SMAPs) were identified, although their mechanisms of action have not been fully defined. Here we explore the interaction of PR65 with two SMAPs, ATUX-8385 and the non-functional DBK-776, using single-molecule optical tweezers, ensemble methods, and computational analysis. In the absence of SMAP, PR65 shows multiple unfolding and refolding transitions, and the force-extension profiles are very heterogeneous with evidence of misfolding. Similar heterogeneity has been observed for chemical-induced unfolding of tandem-repeat proteins like PR65, a consequence of the internal symmetry of the repeat architecture. In the presence of ATUX-8385, higher unfolding and refolding forces are observed globally, and there is less misfolding, suggesting that ATUX-8385 acts like a pharmacological chaperone. In contrast, DBK-766-binding induces higher unfolding forces for only a few repeats of PR65, suggestive of a more localised effect; moreover, subsequent stretch-relax cycles show that PR65 is irreversibly locked in the unfolded state. Docking and molecular dynamics simulations provide additional insights how SMAP binding modulates PR65 structure and function.